What class is the BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark registered in?

The BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV trademark is registered in Class 044 (Medical, veterinary & beauty care services).

What is the serial number for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV?

The USPTO serial number for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV is 98433740.

What is the registration number for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV?

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV is registered under USPTO registration number 7693393.

BRI

USPTO Trademark Record

REGISTERED

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

SN 98433740·Reg 7693393·Filed Mar 05, 2024

Owner TG Therapeutics, Inc.

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV (Serial No. 98433740), Registration No. 7693393, is a registered US trademark filed on Mar 05, 2024 by TG Therapeutics, Inc.. This trademark covers Class 044 (Medical, veterinary & beauty care services).

early section 8: February 18, 2031

Mark Intelligence

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV (Reg. #7693393) is a registered US trademark that has been protecting its owner, TG Therapeutics, Inc., since 2024. The mark covers Class 044 (Medical, veterinary & beauty care services). Goods and services include Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, h.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 05, 2024

SERIAL

98433740

REG#

7693393

REGISTERED

Feb 18, 2025

Owner

Applicant

TG Therapeutics, Inc.

Entity

Corporation

State

Address

2 Gansevoort Street, 9th Floor, New York, NY, 10014

Country

Attorney

NameMaury M. Tepper, III

Law firm

Maury M. Tepper, III Tepper & Eyster, PLLC

Address

3724 Benson Drive, Raleigh, NC 27609, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMar 05, 2024

Serial Number98433740

Registration No.7693393

Registration DateFeb 18, 2025

Status DateFeb 18, 2025

Published for OppositionDec 31, 2024

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Dec 28, 2022

First use in commerce: Dec 28, 2022

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

Feb 18, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 18, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Dec 31, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 31, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 25, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 05, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 03, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 03, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 03, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 23, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 23, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 23, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 18, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 18, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 18, 2024

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Mar 05, 2024

NEW APPLICATION ENTERED

BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by TG Therapeutics, Inc.

Other Marks in Class 044 — Medical, veterinary & beauty care services

Other Marks by Maury M. Tepper, III

Resources

Company